| scholarly article | Q13442814 |
| P2093 | author name string | Gordon H Williams | |
| Michael S Conte | |||
| Takuya Miyahara | |||
| Gail K Adler | |||
| Jose R Romero | |||
| Raouf A Khalil | |||
| Iris Z Jaffe | |||
| Min Park | |||
| Brenna G Newfell | |||
| Richard Bafford | |||
| Xin Xin Sui | |||
| P2860 | cites work | Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosc | Q46231225 |
| Eplerenone suppresses neointimal formation after coronary stent implantation in swine. | Q46603436 | ||
| Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells | Q46636017 | ||
| Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation | Q46902313 | ||
| Differential action of angiotensin II and activity of angiotensin-converting enzyme in human bypass grafts | Q47705038 | ||
| Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis | Q48577521 | ||
| Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein. | Q53659822 | ||
| Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. | Q54194862 | ||
| Mineralocorticoid receptor activation promotes vascular cell calcification | Q64377301 | ||
| Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor | Q67494059 | ||
| Effect of aldosterone on vascular angiotensin II receptors in the rat | Q70132648 | ||
| Angiotensin II receptors in rabbit vascular grafts | Q70534343 | ||
| Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809 | Q71407503 | ||
| Increased concentrations of angiotensin-converting enzyme in the intimal hyperplasia of experimental vein grafts | Q71627360 | ||
| Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart | Q71844423 | ||
| Neointimal thickening after balloon denudation is enhanced by aldosterone and inhibited by spironolactone, and aldosterone antagonist | Q72641908 | ||
| Aldosterone mediates angiotensin II-stimulated rat vascular smooth muscle cell proliferation | Q73790678 | ||
| A novel vein graft model: adaptation to differential flow environments | Q79074009 | ||
| Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial | Q28236480 | ||
| Mechanisms of mineralocorticoid action | Q28281657 | ||
| Effect of torcetrapib on the progression of coronary atherosclerosis | Q28295023 | ||
| Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q28303699 | ||
| The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
| Effects of torcetrapib in patients at high risk for coronary events | Q29619609 | ||
| Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes | Q30273814 | ||
| Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004. | Q31107711 | ||
| Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia | Q33342172 | ||
| Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases | Q33852885 | ||
| Mineralocorticoid selectivity: molecular and cellular aspects | Q33888900 | ||
| Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. | Q34106420 | ||
| The renin angiotensin system in bypass graft surgery | Q34151628 | ||
| Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction | Q34187441 | ||
| Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system | Q36548154 | ||
| The role of aldosterone and mineralocorticoid receptors in cardiovascular disease | Q36870019 | ||
| Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion | Q37003229 | ||
| Aldosterone and vascular inflammation | Q37048931 | ||
| New insights on signaling cascades induced by cross-talk between angiotensin II and aldosterone | Q37119817 | ||
| Lower extremity vein graft failure: a translational approach | Q37121388 | ||
| Reconsidering the roles of the mineralocorticoid receptor | Q37367156 | ||
| Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells | Q38330461 | ||
| Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809. | Q41711724 | ||
| ACE inhibitor and AT1 antagonist blockade of deformation-induced gene expression in the rabbit jugular vein through B2 receptor activation | Q42498136 | ||
| Patterns of treatment for peripheral arterial disease in the United States: 1996-2005. | Q42616709 | ||
| Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial | Q42635113 | ||
| Trends, complications, and mortality in peripheral vascular surgery. | Q42680324 | ||
| Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries | Q43684766 | ||
| Aldosterone induces a vascular inflammatory phenotype in the rat heart | Q44182980 | ||
| 11beta-hydroxysteroid dehydrogenase type 2 in mouse aorta: localization and influence on response to glucocorticoids | Q44553758 | ||
| Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells | Q44907744 | ||
| Mechanism for aldosterone potentiation of angiotensin II-stimulated rat arterial smooth muscle cell proliferation | Q45012637 | ||
| Chronic ACE Inhibition Reduces Intimal Hyperplasia in Experimental Vein Grafts | Q45127970 | ||
| P433 | issue | 1 | |
| P304 | page(s) | H41-7 | |
| P577 | publication date | 2011-05-02 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization | |
| P478 | volume | 301 |
| Q33775560 | Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling |
| Q36476340 | Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice. |
| Q36068308 | Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy |
| Q90347754 | Mineralocorticoid receptor: A hidden culprit for hemodialysis vascular access dysfunction |
| Q34684861 | Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications |
| Q89342718 | New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects |
| Q58086049 | Vascular Mineralocorticoid Receptor: Evolutionary mediator of wound healing turned harmful by our modern lifestyle |
| Q38149507 | Vein graft failure |
Search more.